| Trial ID: | L1783 |
| Source ID: | NCT00479466
|
| Associated Drug: |
Mk0893
|
| Title: |
Dose-Range Finding Study for MK0893 (0893-008)
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00479466/results
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: MK0893|DRUG: Metformin|DRUG: Placebo to MK0893|DRUG: Placebo to Metformin
|
| Outcome Measures: |
Primary: Change From Baseline to Week 12 in Fasting Plasma Glucose (FPG), Week 12 | Secondary: Change From Baseline to Week 12 in Hemoglobin A1c (HbA1c), Week 12|Change From Baseline to Week 12 in 2-Hour Post Prandial Glucose (PPG), Week 12
|
| Sponsor/Collaborators: |
Sponsor: Merck Sharp & Dohme LLC
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
342
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-07
|
| Completion Date: |
2008-05
|
| Results First Posted: |
2011-11-11
|
| Last Update Posted: |
2015-09-09
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00479466
|
